This chapter is set out as follows: History Clinical findings Images Management History Mucosal melanocytic macules are more common in women than men The age at onset is approximately 30 years Clinical findings Distribution The lips are the most common site, especially the central third of the lower lip Morphology Lesions present as brown-black macules, and are usually solitary - s everal lesions should increase the suspicion of a systemic condition such as Peutz-Jeghers syndrome, Addison's disease and multiple lentiginoses (eg the Leopard syndrome) Size - under 1 cm in diameter Once developed the lesions usually remain unchanged in size and colour Dermoscopic examination of oral and genital lesions Benign lesions - diffuse pigmentation with a peculiar parallel pattern of partially linear and partially curvilinear light-brown to dark-brown streaks Melanoma - the combination of blue, grey, or white colour with structureless zones are the strongest indicators of mucosal melanoma Clinical Images Please refer to notes on image rights at bottom of the page with regards to individual image ownership
Novo Nordisk's UBT251, one of its triple agonists, which it is developing in collaboration with a China-based company called The United Laboratories International Holdings Limited, has already shown strong results in phase 2 studies
Tirzepatide for managing overweight and obesity Technology Appraisal TA1026
Side effects: Primarily gastrointestinalnausea, vomiting, diarrhea, and constipationwhich are generally mildtomoderate and transient [4] [5]
Rather than cannibalizing significant market share from injectables, oral formulations are more likely to expand the total patient population eligible for these therapies
The appropriate alternative depends on your individual clinical situation and treatment goals
